TRLS
NEUTRALTrellus Health Grants Share Options to Executives
The healthcare company has granted share options to its top executives as part of their compensation packages.
Trellus Health
1.9500GBX
5.41%
Market Cap
3.15M
Volume
8.59k
1% of avg
P/E Ratio
-0.01
EPS (TTM)
-2.37
Beta
2.3
Day Range
1.7820p - 1.9500p
52 Week Range
0.5000p1.9500p5.4000p
1.9500p
Upcoming Events
31 October 2025
Cash runway extended to
High Impact Event
TRLS
GOODTrellus Health Provides Positive Business Update, Extends Cash Runway
The healthcare company provides a positive business update, extending its cash runway and announcing a new collaboration with a major pharmaceutical partner.
TRLS
GOODTrellus Health Secures Collaboration with Johnson & Johnson to Support IBD Patients
The healthcare company has entered a collaboration with a major pharmaceutical firm to support patients with inflammatory bowel disease, leveraging its digital platform and resilience-based approach.
TRLS
NEUTRALTrellus Health Director Reduces Stake
Small-cap healthcare company Trellus Health sees director reduce stake, potentially impacting sentiment.
TRLS
BADTrellus Health Struggles with Slow Enrollment, Burning Cash
Healthcare tech company struggles with slow growth and cash burn
TRLS
NEUTRALTrellus Health Appoints Experienced Healthcare Executive to Board
Healthcare company appoints industry veteran to board, aiming to drive growth.
TRLS
GOODTrellus Health Announces Interim Results, Highlights Positive Outcomes from Proprietary GRITT Methodology
Healthcare company Trellus Health announces interim results, highlights positive outcomes from its proprietary chronic condition management solution.
TRLS
NEUTRALTrellus Health Sees Major Shareholder Increase Stake
A major investor increases stake in healthcare technology company Trellus Health
TRLS
NEUTRALTrellus Health Announces Change in Major Shareholding
Small-cap healthcare technology company announces minor change in shareholding
TRLS
NEUTRALHarwood Capital Reduces Stake in Trellus Health
Healthcare tech company Trellus Health sees major investor reduce stake